Published in Medical Letter on the CDC and FDA, June 29th, 2008
The presentation will provide detailed preclinical results regarding the use of Celsion's temperature sensitive liposome formulation with docetaxel. This novel encapsulation of a well known chemotherapeutic agent demonstrates improved anti-tumor effect in-vivo. Mice were tumored with a Lewis lung cell line in the leg and then treated in three cohorts: with free docetaxel; docetaxel encapsulated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA